+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Rare Disease Genetic Testing Market by Technology, Test Type, End User, Application, Disease Indication - Global Forecast to 2030- Product Image
Rare Disease Genetic Testing Market by Technology, Test Type, End User, Application, Disease Indication - Global Forecast to 2030- Product Image
Sale

Rare Disease Genetic Testing Market by Technology, Test Type, End User, Application, Disease Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5533238
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Rare Disease Genetic Testing Market is rapidly evolving, driven by advancements in sequencing technology and increasing demand for precise diagnostics. Senior decision-makers face a dynamic environment shaped by regulatory trends, stakeholder priorities, and supply chain shifts.

Market Snapshot: Rare Disease Genetic Testing Market Overview

The Rare Disease Genetic Testing Market grew from USD 1.54 billion in 2024 to USD 1.79 billion in 2025. It is expected to continue growing at a CAGR of 16.28%, reaching USD 3.80 billion by 2030. This expansion reflects the sector’s increasing adoption in clinical, hospital, and research settings, bolstered by continuous platform innovation and broader accessibility. Demand is especially strong in specialized clinics and hospitals, with regional hubs emerging around the globe to address diverse patient populations and diagnostic requirements.

Scope & Segmentation

This report delivers a comprehensive analysis by delving into market structure, regional expansion, and technology trends.

  • Technology: Microarray, next generation sequencing (including sequencing by ligation, sequencing by synthesis), polymerase chain reaction (digital PCR, quantitative PCR).
  • Test Type: Exome sequencing (clinical, research), genome sequencing (targeted, whole), panel tests (cancer, cardiovascular, neurological), single gene tests.
  • End User: Diagnostic laboratories (independent, hospital-affiliated), hospitals (public, private), research institutions, specialty clinics.
  • Application: Carrier screening, diagnostics, newborn screening, prenatal screening (invasive, non-invasive), research applications.
  • Disease Indication: Hematological disorders, metabolic disorders (enzyme deficiencies, mitochondrial disorders), neuromuscular disorders, oncology.
  • Region: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, and others).
  • Major Companies: Illumina, Inc.; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche AG; QIAGEN N.V.; PerkinElmer, Inc.; Bio-Rad Laboratories, Inc.; Myriad Genetics, Inc.; Invitae Corporation; Natera, Inc.; Eurofins Scientific SE.

Key Takeaways

  • Next generation sequencing platforms are reshaping diagnostic procedures, offering clinicians and researchers powerful tools for comprehensive rare disease analysis.
  • Broader adoption of artificial intelligence and machine learning into bioinformatics pipelines is streamlining variant interpretation, enhancing clinical decision-making, and optimizing laboratory operations.
  • Segmented growth is propelled by the expansion of test panels targeting oncology, metabolic, and neuromuscular disorders, underscoring demand from both clinical and research users.
  • Emerging markets in Asia-Pacific and Latin America are strengthening their positions through regional production and newborn screening initiatives supported by government investment.
  • Strategic alliances, platform diversification, and data management partnerships are integral to maintaining market leadership, while new entrants focus on high-throughput microarray reagents and rapid prenatal screening kits.
  • Stakeholders are prioritizing early engagement with regulatory bodies and collaborations with academic medical centers, accelerating novel assay validation and research-driven care pathways.

Tariff Impact on Genetic Testing Supply Chains

The introduction of cumulative tariffs on imported reagents, instruments, and consumables in 2025 has impacted U.S. genetic testing supply chains and cost structures. Providers are reassessing contracts, exploring regional suppliers, and employing domestic partnerships to reduce exposure to international trade fluctuations. Measures such as service bundling and co-development collaborations with reagent manufacturers have emerged to help manage increased costs, while long-term resilience depends on ongoing supply chain optimization and active policy engagement.

Methodology & Data Sources

This report draws from in-depth primary interviews with executives, laboratory leads, and regulatory professionals in key global regions. Analysis is supplemented by secondary research of peer-reviewed publications, industry reports, regulatory filings, and conference proceedings. Segmentation and regional data were validated using industry benchmarks and multi-tier expert reviews to ensure reliability.

Why This Report Matters

  • Enables leaders to identify technology adoption trends and emerging market hotspots for targeted investment.
  • Provides clarity on evolving regulatory frameworks, supply chain strategies, and potential tariff implications for sustained operations.
  • Offers actionable insights into collaboration models across research, clinical, and commercial sectors to inform strategic growth and innovation planning.

Conclusion

The Rare Disease Genetic Testing Market is marked by rapid transformation across platforms, user segments, and geographies. This report empowers decision-makers with strategic insights to capitalize on innovations, manage disruption, and achieve long-term growth objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Rare Disease Genetic Testing Market, by Technology
8.1. Introduction
8.2. Microarray
8.3. Next Generation Sequencing
8.3.1. Sequencing by Ligation
8.3.2. Sequencing by Synthesis
8.4. Polymerase Chain Reaction
8.4.1. Digital PCR
8.4.2. Quantitative PCR
9. Rare Disease Genetic Testing Market, by Test Type
9.1. Introduction
9.2. Exome Sequencing
9.2.1. Clinical Exome
9.2.2. Research Exome
9.3. Genome Sequencing
9.3.1. Targeted Genome
9.3.2. Whole Genome
9.4. Panel Test
9.4.1. Cancer Panels
9.4.2. Cardiovascular Panels
9.4.3. Neurological Panels
9.5. Single Gene Test
10. Rare Disease Genetic Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Research Institutions
10.5. Specialty Clinics
11. Rare Disease Genetic Testing Market, by Application
11.1. Introduction
11.2. Carrier Screening
11.3. Diagnostics
11.4. Newborn Screening
11.5. Prenatal Screening
11.5.1. Invasive
11.5.2. Non Invasive
11.6. Research Applications
12. Rare Disease Genetic Testing Market, by Disease Indication
12.1. Introduction
12.2. Hematological Disorders
12.3. Metabolic Disorders
12.3.1. Enzyme Deficiencies
12.3.2. Mitochondrial Disorders
12.4. Neuromuscular Disorders
12.5. Oncology
13. Americas Rare Disease Genetic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Rare Disease Genetic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Rare Disease Genetic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Illumina, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. F. Hoffmann-La Roche AG
16.3.4. QIAGEN N.V.
16.3.5. PerkinElmer, Inc.
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Myriad Genetics, Inc.
16.3.8. Invitae Corporation
16.3.9. Natera, Inc.
16.3.10. Eurofins Scientific SE
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RARE DISEASE GENETIC TESTING MARKET MULTI-CURRENCY
FIGURE 2. RARE DISEASE GENETIC TESTING MARKET MULTI-LANGUAGE
FIGURE 3. RARE DISEASE GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RARE DISEASE GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RARE DISEASE GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RARE DISEASE GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CLINICAL EXOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH EXOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TARGETED GENOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY WHOLE GENOME, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CANCER PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARDIOVASCULAR PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROLOGICAL PANELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SINGLE GENE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NON INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ENZYME DEFICIENCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEUROMUSCULAR DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL RARE DISEASE GENETIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 86. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 87. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 88. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 89. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 90. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 91. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 93. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 95. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 96. CANADA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 97. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 99. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 100. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 102. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 103. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 104. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 108. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 163. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 165. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 166. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 167. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 168. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 169. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 170. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 174. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 175. GERMANY RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 176. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 178. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 180. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 181. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 182. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 183. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 185. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 187. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 188. FRANCE RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 198. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 200. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 201. RUSSIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 202. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 204. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 205. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 206. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 207. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 208. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 209. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 211. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 213. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 214. ITALY RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 215. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 217. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 218. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 220. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 221. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 222. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 226. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 227. SPAIN RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 239. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 240. UNITED ARAB EMIRATES RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 246. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 248. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 250. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 252. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 253. SAUDI ARABIA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 254. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 256. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 258. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 260. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 261. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 263. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 265. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 266. SOUTH AFRICA RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 267. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 268. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 269. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 270. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 272. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 273. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 274. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 278. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 279. DENMARK RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 280. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 283. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 284. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 285. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 286. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 287. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 289. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 290. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 291. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 292. NETHERLANDS RARE DISEASE GENETIC TESTING MARKET SIZE, BY METABOLIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 293. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 295. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 296. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 297. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY EXOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 298. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY GENOME SEQUENCING, 2018-2030 (USD MILLION)
TABLE 299. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY PANEL TEST, 2018-2030 (USD MILLION)
TABLE 300. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. QATAR RARE DISEASE GENETIC TESTING MARKET SIZE, BY PRENATAL SCREENING, 2018-2030 (USD MILLION)
TABLE 304. QATAR RARE DISEASE GENETIC TESTING MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Rare Disease Genetic Testing market report include:
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • QIAGEN N.V.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics, Inc.
  • Invitae Corporation
  • Natera, Inc.
  • Eurofins Scientific SE

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.79 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.8 Billion
Compound Annual Growth Rate16.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease (Neurological Disorders), By Technology (Next Generation Sequencing, Array Technology, PCR-based Testing), By Specialty, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Rare Disease Genetic Testing Market Size, Share & Trends Analysis Report By Disease (Neurological Disorders), By Technology (Next Generation Sequencing, Array Technology, PCR-based Testing), By Specialty, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Predictive Genetics Market by Technology, Test Type, Application, End User, Product Type - Global Forecast to 2030 - Product Image

Predictive Genetics Market by Technology, Test Type, Application, End User, Product Type - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Rare Disease Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Rare Disease Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 188 Pages
  • Global
From
Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Image

Global Hereditary Genetic Testing Market: Focus on Product, Sample Type, Technology, Genetic Testing Type, Application Area, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • 113 Pages
  • Global
From
Whole Genome and Exome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Whole Genome and Exome Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From

About the Rare Disease Genetic Testing Market

The Rare Disease Genetic Testing market is a subset of the larger Genomics market. It focuses on the diagnosis and treatment of rare genetic diseases, which are caused by mutations in a single gene. These tests are used to identify the genetic cause of a disease, as well as to predict the risk of developing a disease in the future. They can also be used to identify the best treatment options for a particular patient. The Rare Disease Genetic Testing market is growing rapidly, driven by advances in technology and the increasing availability of genetic testing services. This has enabled more accurate diagnosis and treatment of rare diseases, as well as the development of new treatments. Companies in the Rare Disease Genetic Testing market include Ambry Genetics, Invitae, Counsyl, and GeneDx. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.